TP53 and melanoma: Nutlin-3 combined with vemurafenib (inhibitor of mutant Raf) synergistically induced apoptosis and suppressed melanoma cell viability in vitro and tumor growth in vivo, suggesting that reactivation of p53 by nutlins overcomes vemurafenib resistance in melanoma [160].